Wart Remover Liquid
NDC 87298-012
Product Information
Wart Remover Liquid (salicylic acid) is a OTC MONOGRAPH DRUG-approved product labeled by Guangzhou Hechuang Commercial Service Co.,ltd.. This medication is used on the skin to treat common skin and foot (plantar) warts. It is supplied as a liquid for cutaneous; extracorporeal; intraepidermal administration. This product entry covers the primary NDC 87298-012 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Cutaneous - Administration to the skin.
- Extracorporeal - Administration outside of the body.
- Intraepidermal - Administration within the epidermis.
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 87298-012?
What are the uses of this product?
What are Active Ingredients of this product?
- SALICYLIC ACID 8 g/100g - A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SALICYLIC ACID (UNII: O414PZ4LPZ)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANGELICA SINENSIS ROOT (UNII: B66F4574UG)
- POVIDONE-IODINE (UNII: 85H0HZU99M)
- SOPHORA FLAVESCENS ROOT (UNII: IYR6K8KQ5K)
- LITHOSPERMUM ERYTHRORHIZON ROOT (UNII: 9I70D8O47I)
- BRUCEA JAVANICA WHOLE (UNII: Z4CCI5NZ66)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 252577 - salicylic acid 8 % Topical Solution
- RxCUI: 252577 - salicylic acid 80 MG/ML Topical Solution
* Please review the full disclaimer at the bottom of this page.